In the Brain Tumor Center, the care we provide is driven by the latest research. Our team members are leaders in pediatric brain tumor research — and our findings are helping improve our understanding of brain tumors and transform their treatment.
In 2023, Sophia Mordini landed the role of a lifetime. A competitive dancer, the 12-year-old would play Clara in her company’s production of “The Nutcracker.” But the performance was bittersweet:…
Children are much more likely to survive cancer today than 50 years ago. Unfortunately, as adults, many of them develop cardiovascular disease, secondary cancers, or both, believed to result from the…
Pediatric high-grade gliomas, particularly H3K27M diffuse midline gliomas (DMG), are aggressive malignant brain tumors with a poor prognosis. Previous research suggests that platelet-derived growth…
The Brain Tumor Center is a member of several major clinical trial consortia. These include the Children’s Oncology Group (COG), the Pediatric Neuro-Oncology Consortium (PNOC), the CONNECT Consortium, and the Pediatric Brain Tumor Consortium (PBTC). This means that we can provide our patients with access to a wide range of clinical trials.
